Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Early Vigabatrin Treatment Before Seizure Onset Decreased Interictal Epileptiform Discharges Over the Duration of the PREVeNT Study.
Journal: Pediatric neurology
Published: December 29, 2025
Neurodevelopmental Outcomes From the PREVeNT Trial.
Journal: Pediatric neurology
Published: March 10, 2025
Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial.
Journal: Pediatric neurology
Published: March 05, 2024
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial.
Journal: Annals of neurology
Published: May 24, 2023
Risk of seizure recurrence after achieving initial seizure freedom on the ketogenic diet.
Journal: Epilepsia
Published: January 27, 2014
Telemedicine for genetic and neurologic evaluation in the neonatal intensive care unit.
Journal: Journal of perinatology : official journal of the California Perinatal Association
Published: July 15, 2013
Anti-NMDA receptor encephalitis presenting with focal non-convulsive status epilepticus in a child.
Journal: Neuropediatrics
Published: November 24, 2011
Showing 1-7 of 7
Last Updated: 09/26/2026